Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Borràs J[au]:

Search results

Items: 1 to 50 of 367

1.

A SYSTEMATIC AND COMPREHENSIVE REVIEW OF INTERNET USE IN CANCER PATIENTS: PSYCHOLOGICAL FACTORS.

Lleras de Frutos M, Casellas-Grau A, Sumalla EC, de Gracia M, Borràs JM, Ochoa Arnedo C.

Psychooncology. 2019 Aug 5. doi: 10.1002/pon.5194. [Epub ahead of print] Review.

PMID:
31385400
2.

National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project.

Defourny N, Perrier L, Borras JM, Coffey M, Corral J, Hoozée S, Loon JV, Grau C, Lievens Y.

Radiother Oncol. 2019 Jul 15;138:187-194. doi: 10.1016/j.radonc.2019.06.015. [Epub ahead of print]

PMID:
31319281
3.

Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma.

Diaz-Mercedes S, Archilla I, Camps J, de Lacy A, Gorostiaga I, Momblan D, Ibarzabal A, Maurel J, Chic N, Bombí JA, Balaguer F, Castells A, Aldecoa I, Borras JM, Cuatrecasas M.

Appl Health Econ Health Policy. 2019 May 21. doi: 10.1007/s40258-019-00482-7. [Epub ahead of print]

PMID:
31115896
4.

Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis.

de la Cueva Dobao P, Notario J, Ferrándiz C, López Estebaranz JL, Alarcón I, Sulleiro S, Borrás J, Daudén E, Carrascosa JM, Sánchez Carazo JL, Monte Boquet E, Puig L.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1214-1223. doi: 10.1111/jdv.15600. Epub 2019 Apr 29.

PMID:
31037770
5.

Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain.

Font R, Espinas JA, Barnadas A, Izquierdo A, Galceran J, Saladie F, Marcos-Gragera R, Torrent A, Manchon-Walsh P, Borras JM.

Breast Cancer Res Treat. 2019 Jun;175(3):733-740. doi: 10.1007/s10549-019-05201-3. Epub 2019 Mar 18.

PMID:
30887164
6.

Hypothesized Epitope Localization in Hypersensitivity Reactions to Iodinated Contrast Media.

Borras J, El-Qutob D, Lopez R, Enrique E.

J Investig Allergol Clin Immunol. 2019 Feb;29(1):82-83. doi: 10.18176/jiaci.0341. No abstract available.

7.

Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona.

Ameijide A, Clèries R, Carulla M, Buxó M, Marcos-Gragera R, Martínez JM, Vilardell ML, Vilardell M, Espinàs JA, Borràs JM, Izquierdo Á, Galceran J.

Clin Transl Oncol. 2019 Aug;21(8):1014-1025. doi: 10.1007/s12094-018-02015-5. Epub 2019 Jan 3.

PMID:
30607790
8.

A propensity-score-matched analysis of laparoscopic vs open surgery for rectal cancer in a population-based study.

Manchon-Walsh P, Aliste L, Biondo S, Espin E, Pera M, Targarona E, Pallarès N, Vernet R, Espinàs JA, Guarga A, Borràs JM.

Colorectal Dis. 2019 Apr;21(4):441-450. doi: 10.1111/codi.14545. Epub 2019 Jan 17.

PMID:
30585686
9.

[Excess mortality among breast cancer patients in early stages in Tarragona and Gerona (Spain)].

Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Marcos-Gragera R, Vilardell ML, Carulla M, Espinàs JA, Galceran J, Borràs JM, Izquierdo Á.

Gac Sanit. 2018 Dec 17. pii: S0213-9111(18)30244-9. doi: 10.1016/j.gaceta.2018.09.008. [Epub ahead of print] Spanish.

10.

Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.

Pérez-Beteta J, Molina-García D, Martínez-González A, Henares-Molina A, Amo-Salas M, Luque B, Arregui E, Calvo M, Borrás JM, Martino J, Velásquez C, Meléndez-Asensio B, de Lope ÁR, Moreno R, Barcia JA, Asenjo B, Benavides M, Herruzo I, Lara PC, Cabrera R, Albillo D, Navarro M, Pérez-Romasanta LA, Revert A, Arana E, Pérez-García VM.

Eur Radiol. 2019 May;29(5):2729. doi: 10.1007/s00330-018-5870-8.

PMID:
30547198
11.

Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.

Pérez-Beteta J, Molina-García D, Martínez-González A, Henares-Molina A, Amo-Salas M, Luque B, Arregui E, Calvo M, Borrás JM, Martino J, Velásquez C, Meléndez-Asensio B, de Lope ÁR, Moreno R, Barcia JA, Asenjo B, Benavides M, Herruzo I, Lara PC, Cabrera R, Albillo D, Navarro M, Pérez-Romasanta LA, Revert A, Arana E, Pérez-García VM.

Eur Radiol. 2019 Apr;29(4):1968-1977. doi: 10.1007/s00330-018-5758-7. Epub 2018 Oct 15. Erratum in: Eur Radiol. 2018 Dec 13;:.

PMID:
30324390
12.

[Participation of the immigrant population in breast cancer screening in Tarragona, Spain].

Laroussy L, Ameijide A, Saladié F, Espinàs JA, Borràs JM, Galceran J.

Gac Sanit. 2018 Sep 8. pii: S0213-9111(18)30159-6. doi: 10.1016/j.gaceta.2018.05.010. [Epub ahead of print] Spanish.

13.

Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium.

Groen JV, Sibinga Mulder BG, van Eycken E, Valerianova Z, Borras JM, van der Geest LGM, Capretti G, Schlesinger-Raab A, Primic-Zakelj M, Ryzhov A, van de Velde CJH, Bonsing BA, Bastiaannet E, Mieog JSD.

Ann Surg Oncol. 2018 Nov;25(12):3492-3501. doi: 10.1245/s10434-018-6705-1. Epub 2018 Aug 27.

PMID:
30151560
14.

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.

Cantero D, Rodríguez de Lope Á, Moreno de la Presa R, Sepúlveda JM, Borrás JM, Castresana JS, D'Haene N, García JF, Salmon I, Mollejo M, Rey JA, Hernández-Laín A, Meléndez B.

J Neuropathol Exp Neurol. 2018 Aug 1;77(8):710-716. doi: 10.1093/jnen/nly048.

PMID:
30010995
15.

Substance use disorders in patients with intellectual disability admitted to psychiatric hospitalisation.

Salavert J, Clarabuch A, Fernández-Gómez MJ, Barrau V, Giráldez MP, Borràs J.

J Intellect Disabil Res. 2018 Nov;62(11):923-930. doi: 10.1111/jir.12514. Epub 2018 Jul 1.

PMID:
29961996
16.

Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.

Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA, Fernández-Romero A, Luque B, Arregui E, Calvo M, Borrás JM, Meléndez B, Rodríguez de Lope Á, Moreno de la Presa R, Iglesias Bayo L, Barcia JA, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Revert A, Arana E, Pérez-García VM.

Radiology. 2018 Jul;288(1):218-225. doi: 10.1148/radiol.2018171051.

PMID:
29924716
17.

The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study.

Delgado-Ortega L, González-Domínguez A, Borrás JM, Oliva-Moreno J, González-Haba E, Menjón S, Pérez P, Vicente D, Cordero L, Jiménez M, Simón S, Hidalgo-Vega Á, Moya-Alarcón C.

Eur J Health Econ. 2019 Feb;20(1):135-147. doi: 10.1007/s10198-018-0986-y. Epub 2018 Jun 19.

18.

Influence of age on variation in patterns of care in patients with rectal cancer in Catalonia (Spain).

Vernet R, Borras JM, Aliste L, Antonio M, Guarga A, Manchon-Walsh P.

Clin Transl Oncol. 2018 Dec;20(12):1538-1547. doi: 10.1007/s12094-018-1882-8. Epub 2018 May 15.

PMID:
29766457
19.

The role of posttraumatic stress and posttraumatic growth on online information use in breast cancer survivors.

Casellas-Grau A, Sumalla EC, Lleras M, Vives J, Sirgo A, León C, Rodríguez A, Campos G, Valverde Y, Borràs JM, Ochoa C.

Psychooncology. 2018 Aug;27(8):1971-1978. doi: 10.1002/pon.4753. Epub 2018 May 25.

PMID:
29740909
20.

Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.

Cabezón M, Bargay J, Xicoy B, García O, Borrás J, Tormo M, Marcé S, Pedro C, Valcárcel D, Jiménez MJ, Guàrdia R, Palomo L, Brunet S, Vall-Llovera F, Garcia A, Feliu E, Zamora L; CETLAM Group.

Oncotarget. 2018 Apr 10;9(27):19342-19355. doi: 10.18632/oncotarget.25046. eCollection 2018 Apr 10.

21.

Clinical Audit of the Radiotherapy Process in Rectal Cancer: Clinical Practice Guidelines and Quality Certification Do Not Avert Variability in Clinical Practice.

Torras MG, Canals E, Jurado-Bruggeman D, Marín-Borras S, Macià M, Jové J, Boladeras AM, Muñoz-Montplet C, Molero J, Picón C, Puigdemont M, Aliste L, Torrents A, Guedea F, Borras JM.

Transl Oncol. 2018 Jun;11(3):794-799. doi: 10.1016/j.tranon.2018.03.015. Epub 2018 Apr 26.

22.

Long-term crude probabilities of death among breast cancer patients by age and stage: a population-based survival study in Northeastern Spain (Girona-Tarragona 1985-2004).

Clèries R, Ameijide A, Buxó M, Martínez JM, Marcos-Gragera R, Vilardell ML, Carulla M, Yasui Y, Vilardell M, Espinàs JA, Borràs JM, Galceran J, Izquierdo À.

Clin Transl Oncol. 2018 Oct;20(10):1252-1260. doi: 10.1007/s12094-018-1852-1. Epub 2018 Mar 6.

23.

Germline promoter hypermethylation in BRCA1 and BRCA2 genes is not present in hereditary breast cancer patients.

Rodríguez-Balada M, Roig B, Melé M, Salvat M, Martorell L, Borràs J, Gumà J.

Clin Transl Oncol. 2018 Sep;20(9):1226-1231. doi: 10.1007/s12094-018-1837-0. Epub 2018 Feb 5.

PMID:
29404838
24.

Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer.

Antonio M, Saldaña J, Linares J, Ruffinelli JC, Palmero R, Navarro A, Arnaiz MD, Brao I, Aso S, Padrones S, Navarro V, González-Barboteo J, Borràs JM, Cardenal F, Nadal E.

Br J Cancer. 2018 Mar 6;118(5):639-647. doi: 10.1038/bjc.2017.455. Epub 2018 Jan 30.

25.

[WebSurvCa: web-based estimation of death and survival probabilities in a cohort].

Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Alarcón F, Cordero D, Díez-Villanueva A, Yasui Y, Marcos-Gragera R, Vilardell ML, Carulla M, Galceran J, Izquierdo Á, Moreno V, Borràs JM.

Gac Sanit. 2018 Sep - Oct;32(5):492-495. doi: 10.1016/j.gaceta.2017.10.015. Epub 2018 Jan 19. Spanish.

26.

Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer.

Roig B, Rodríguez-Balada M, Samino S, Lam EW, Guaita-Esteruelas S, Gomes AR, Correig X, Borràs J, Yanes O, Gumà J.

Sci Rep. 2017 Dec 19;7(1):17831. doi: 10.1038/s41598-017-17897-8.

27.

Revisiting the thiosemicarbazonecopper(II) reaction with glutathione. Activity against colorectal carcinoma cell lines.

García-Tojal J, Gil-García R, Fouz VI, Madariaga G, Lezama L, Galletero MS, Borrás J, Nollmann FI, García-Girón C, Alcaraz R, Cavia-Saiz M, Muñiz P, Palacios Ò, Samper KG, Rojo T.

J Inorg Biochem. 2018 Mar;180:69-79. doi: 10.1016/j.jinorgbio.2017.12.005. Epub 2017 Dec 8.

PMID:
29247869
28.

Managing cancer care through service delivery networks: The role of professional collaboration in two European cancer networks.

Prades J, Morando V, Tozzi VD, Verhoeven D, Germà JR, Borras JM.

Health Serv Manage Res. 2018 Aug;31(3):120-129. doi: 10.1177/0951484817745219. Epub 2017 Dec 14.

PMID:
29239683
29.

Estimating the number of fractions by tumour site for European countries in 2012 and 2025: An ESTRO-HERO analysis.

Borras JM, Grau C, Corral J, Wong K, Barton MB, Ferlay J, Bray F, Lievens Y.

Radiother Oncol. 2018 Feb;126(2):198-204. doi: 10.1016/j.radonc.2017.11.009. Epub 2017 Nov 29.

PMID:
29198408
30.

Definition of a SNOMED CT pathology subset and microglossary, based on 1.17 million biological samples from the Catalan Pathology Registry.

Sanz X, Pareja L, Rius A, Rodenas P, Abdón N, Gálvez J, Esteban L, Escribà JM, Borràs JM, Ribes J.

J Biomed Inform. 2018 Feb;78:167-176. doi: 10.1016/j.jbi.2017.11.010. Epub 2017 Nov 20.

31.

Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.

Antonio M, Carmona-Bayonas A, Saldaña J, Navarro V, Tebé C, Salazar R, Borràs JM.

Clin Colorectal Cancer. 2018 Mar;17(1):e59-e68. doi: 10.1016/j.clcc.2017.09.003. Epub 2017 Sep 28.

PMID:
29054805
32.

Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly.

Clèries R, Ameijide A, Marcos-Gragera R, Pareja L, Carulla M, Vilardell ML, Esteban L, Buxó M, Espinàs JA, Puigdefàbregas A, Ribes J, Izquierdo A, Galceran J, Borrás JM.

Clin Transl Oncol. 2018 May;20(5):647-657. doi: 10.1007/s12094-017-1764-5. Epub 2017 Oct 12.

33.

Summary statement on screening for prostate cancer in Europe.

Heijnsdijk EAM, Bangma CH, Borràs JM, de Carvalho TM, Castells X, Eklund M, Espinàs JA, Graefen M, Grönberg H, Lansdorp-Vogelaar I, Leeuwen PJV, Nelen V, Recker F, Roobol MJ, Vandenbulcke P, de Koning HJ.

Int J Cancer. 2018 Feb 15;142(4):741-746. doi: 10.1002/ijc.31102. Epub 2017 Oct 25.

34.

Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre.

Saigí M, Oliva M, Aliste L, Calvo M, Hormigo G, Serra Ò, Boladeras A, Farran L, Robles J, Creus G, Paúles MJ, Gornals JB, de Lama E, Borràs JM, Sala N, Galán M.

PLoS One. 2017 Sep 20;12(9):e0184737. doi: 10.1371/journal.pone.0184737. eCollection 2017.

35.

Improving radiation oncology through clinical audits: Introducing the IROCA project.

Torras MG, Fundowicz M, Aliste L, Asensio E, Boladeras AM, Borràs JM, Carvalho L, Castro C, Deantonio L, Konstanty E, Krengli M, Kruszyna M, Lencart J, Macià M, Marín S, Muñoz-Montplet C, Pisani C, Pinto D, Puigdemont M, Guedea F, Aguiar A, Milecki P, Malicki J.

Rep Pract Oncol Radiother. 2017 Sep-Oct;22(5):408-414. doi: 10.1016/j.rpor.2017.07.004. Epub 2017 Aug 11.

36.

Towards the centralization of digestive oncologic surgery: changes in activity, techniques and outcome.

Tebé C, Pla R, Espinàs JA, Corral J, Puigdomenech E, Borràs JM, Pons JMV, Espallargues M.

Rev Esp Enferm Dig. 2017 Sep;109(9):634-642. doi: 10.17235/reed.2017.4710/2016.

37.

Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020.

Clèries R, Rooney RM, Vilardell M, Espinàs JA, Dyba T, Borras JM.

Clin Transl Oncol. 2018 Mar;20(3):313-321. doi: 10.1007/s12094-017-1718-y. Epub 2017 Jul 19.

38.

Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.

Guaita-Esteruelas S, Saavedra-García P, Bosquet A, Borràs J, Girona J, Amiliano K, Rodríguez-Balada M, Heras M, Masana L, Gumà J.

Oncologist. 2017 Nov;22(11):1309-1315. doi: 10.1634/theoncologist.2016-0483. Epub 2017 Jul 12.

39.

Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?

Antonio M, Saldaña J, Carmona-Bayonas A, Navarro V, Tebé C, Nadal M, Formiga F, Salazar R, Borràs JM.

Oncologist. 2017 Aug;22(8):934-943. doi: 10.1634/theoncologist.2016-0462. Epub 2017 May 9.

40.

An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer.

Zerillo JA, Schouwenburg MG, van Bommel ACM, Stowell C, Lippa J, Bauer D, Berger AM, Boland G, Borras JM, Buss MK, Cima R, Van Cutsem E, van Duyn EB, Finlayson SRG, Hung-Chun Cheng S, Langelotz C, Lloyd J, Lynch AC, Mamon HJ, McAllister PK, Minsky BD, Ngeow J, Abu Hassan MR, Ryan K, Shankaran V, Upton MP, Zalcberg J, van de Velde CJ, Tollenaar R; Colorectal Cancer Working Group of the International Consortium for Health Outcomes Measurement (ICHOM).

JAMA Oncol. 2017 May 1;3(5):686-694. doi: 10.1001/jamaoncol.2017.0417.

PMID:
28384684
41.

Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?

Font R, Espinas JA, Layos L, Martinez Villacampa M, Capdevila J, Tobeña M, Pisa A, Pericay C, Lezcano C, Fort E, Cardona I, Berga N, Solà J, Borras JM.

Ann Oncol. 2017 Apr 1;28(4):831-835. doi: 10.1093/annonc/mdx006.

42.

Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study.

Prades J, Algara M, Espinàs JA, Farrús B, Arenas M, Reyes V, García-Reglero V, Cambra MJ, Rubio E, Anglada L, Eraso A, Pedro A, Fuentes-Raspall MJ, Tuset V, Solà J, Borras JM.

Radiother Oncol. 2017 Apr;123(1):22-28. doi: 10.1016/j.radonc.2017.01.014. Epub 2017 Feb 21.

43.

The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5.

Guaita-Esteruelas S, Gumà J, Masana L, Borràs J.

Mol Cell Endocrinol. 2018 Feb 15;462(Pt B):107-118. doi: 10.1016/j.mce.2017.02.002. Epub 2017 Feb 3. Review.

PMID:
28163102
44.

Positive psychotherapy for distressed cancer survivors: Posttraumatic growth facilitation reduces posttraumatic stress.

Ochoa C, Casellas-Grau A, Vives J, Font A, Borràs JM.

Int J Clin Health Psychol. 2017 Jan-Apr;17(1):28-37. doi: 10.1016/j.ijchp.2016.09.002. Epub 2016 Oct 18.

45.

Trends in net survival from skin malignant melanoma in six European Latin countries: results from the SUDCAN population-based study.

Galceran J, Uhry Z, Marcos-Gragera R, Borràs J; GRELL EUROCARE-5 Working Group.

Eur J Cancer Prev. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S77-S84. doi: 10.1097/CEJ.0000000000000306.

PMID:
28005609
46.

In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample.

Rodríguez-Balada M, Roig B, Martorell L, Melé M, Salvat M, Vilella E, Borràs J, Gumà J.

Cancer Genet. 2016 Nov;209(11):487-492. doi: 10.1016/j.cancergen.2016.09.003. Epub 2016 Sep 20.

PMID:
27886673
47.

A consensus statement on the gender perspective in lung cancer.

Isla D, Majem M, Viñolas N, Artal A, Blasco A, Felip E, Garrido P, Remón J, Baquedano M, Borrás JM, Die Trill M, García-Campelo R, Juan O, León C, Lianes P, López-Ríos F, Molins L, Planchuelo MÁ, Cobo M, Paz-Ares L, Trigo JM, de Castro J.

Clin Transl Oncol. 2017 May;19(5):527-535. doi: 10.1007/s12094-016-1578-x. Epub 2016 Nov 24. Review.

PMID:
27885542
48.

Estimating long-term crude probability of death among young breast cancer patients: a Bayesian approach.

Clèries R, Buxó M, Yasui Y, Marcos-Gragera R, Martínez JM, Ameijide A, Galceran J, Borràs JM, Izquierdo À.

Tumori. 2016 Dec 1;102(6):555-561. doi: 10.5301/tj.5000545. Epub 2016 Sep 20.

PMID:
27647229
49.

HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia.

Saballs M, Parra S, Sahun P, Pellejà J, Feliu M, Vasco C, Gumà J, Borràs JL, Masana L, Castro A.

Springerplus. 2016 Sep 6;5(1):1491. doi: 10.1186/s40064-016-3145-x. eCollection 2016.

50.

Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.

Manchon-Walsh P, Aliste L, Espinàs JA, Prades J, Guarga A, Balart J, Biondo S, Castells A, Sanjuan X, Tabernero J, Borras JM; Catalonian Rectal Cancer Group.

Eur J Surg Oncol. 2016 Dec;42(12):1873-1880. doi: 10.1016/j.ejso.2016.08.009. Epub 2016 Aug 25.

PMID:
27624916

Supplemental Content

Loading ...
Support Center